Cochrane Clinical Answers
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically focused entry point to rigorous research from Cochrane systematic reviews. They are designed to be actionable and to inform decision making at the point of care and have been added to relevant sections of the main Best Practice text.
- Is there randomized controlled trial evidence to support the use of nimodipine in people with primary degenerative, mixed and vascular dementia?
Use of this content is subject to our disclaimer